India, April 28 -- Insulet Corp. (PODD), a medical device company, on Monday announced that Chief Executive Officer Jim Hollingshead has resigned from the Board of Directors. Additionally, the company's Board has appointed Ashley McEvoy as President and CEO, and a member of the Board of Directors.
After a mutual decision with the Board, McEvoy will replace Jim Hollingshead as Insulet's CEO, effective April 28.
Hollingshead will serve as a consultant to support a smooth leadership transition.
Ashley McEvoy, with three decades of experience in the healthcare sector and had previously worked with Johnson & Johnson's MedTech business and Vision and Diabetes Care.
Looking ahead, the tubeless insulin pump technology company, expects its first...